The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma.

Autor: Nieto C; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Miller B; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Alzofon N; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Chimed T; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Himes J; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Joshi M; Department of Pharmacology, UCDSOM, Aurora, CO, USA., Gomez K; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Chowdhury FN; Department of Otolaryngology, UCDSOM, Aurora, CO, USA., Le PN; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Weaver A; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Somerset H; Department of Pathology, UCDSOM, Aurora, CO, USA., Morton JJ; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Wang JH; Department of Immunology and Microbiology, UCDSOM, Aurora, CO, USA.; University of Pittsburgh Medical Center Hillman Cancer Center, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Wang XJ; Department of Pathology, UCDSOM, Aurora, CO, USA.; Department of Pathology, University of California Davis, Davis, CA, USA., Gao D; Department of Pediatrics, UCDSOM, Aurora, CO, USA., Hansen K; Department of Biochemistry and Molecular Genetics, UCDSOM, Aurora, CO, USA., Keysar SB; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA., Jimeno A; Division of Medical Oncology, Department of Medicine, University of Colorado Denver, School of Medicine (UCDSOM), Aurora, CO, USA.; Gates Center for Regenerative Medicine, UCDSOM, Aurora, CO, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Nov 08; Vol. 115 (11), pp. 1392-1403.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression.

Autor: Alzofon N; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado., Koc K; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado., Panwell K; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado., Pozdeyev N; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado.; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado, Aurora, Colorado., Marshall CB; Department of Pathology, University of Colorado, Aurora, Colorado., Albuja-Cruz M; Division of Trauma, GI and Endocrine Surgery, Department of Surgery, University of Colorado, Aurora, Colorado., Raeburn CD; Division of Trauma, GI and Endocrine Surgery, Department of Surgery, University of Colorado, Aurora, Colorado., Nathanson KL; Department of Medicine, Translational Medicine Division and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Cohen DL; Renal and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Wierman ME; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado.; Research Service, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado., Kiseljak-Vassiliades K; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado.; Research Service, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado., Fishbein L; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado. lauren.fishbein@cuanschutz.edu.; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado, Aurora, Colorado.

Publikováno v: Molecular cancer research : MCR [Mol Cancer Res] 2021 Sep; Vol. 19 (9), pp. 1476-1485. Date of Electronic Publication: 2021 May 13.

Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft.

Autor: Morton JJ; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Alzofon N; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Keysar SB; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Chimed TS; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Reisinger J; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Perrenoud L; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Le PN; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Nieto C; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Gomez K; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Miller B; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Yeager R; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Gao D; Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, Colorado., Tan AC; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.; Department of Biostatistics and Informatics, University of Colorado School of Medicine, Aurora, Colorado., Somerset H; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado., Medina T; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Wang XJ; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado.; Charles C. Gates Center for Regenerative Medicine, University of Colorado School of Medicine, Aurora, Colorado.; Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, Colorado., Wang JH; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado., Robinson W; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Roop DR; Charles C. Gates Center for Regenerative Medicine, University of Colorado School of Medicine, Aurora, Colorado., Gonzalez R; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Jimeno A; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. Antonio.Jimeno@cuanschutz.edu.; Charles C. Gates Center for Regenerative Medicine, University of Colorado School of Medicine, Aurora, Colorado.

Publikováno v: Molecular cancer research : MCR [Mol Cancer Res] 2021 Feb; Vol. 19 (2), pp. 346-357. Date of Electronic Publication: 2020 Oct 21.

Cell Culture Models for Translational Research on Thymomas and Thymic Carcinomas: Current Status and Future Perspectives.

Autor: Müller, Denise¹ (AUTHOR) denise.mueller@med.uni-goettingen.de, Loskutov, Jürgen² (AUTHOR) manuela.regenbrecht@asc-oncology.com, Küffer, Stefan¹ (AUTHOR) christian.regenbrecht@asc-oncology.com, Marx, Alexander¹ (AUTHOR), Regenbrecht, Christian R. A.^1,2,3 (AUTHOR), Ströbel, Philipp¹ (AUTHOR), Regenbrecht, Manuela J.^2,3,4 (AUTHOR)

Publikováno v: Cancers. Aug2024, Vol. 16 Issue 15, p2762. 12p.